|
Sponsor Background
About the Sumitomo Chemical Company
Founded in 1913, Sumitomo Chemical has grown to be a leading multinational
chemical company with sales amounting to US$11.0 billion and 19,000
employees around the world.
The company offers a diverse range of products, including petrochemicals,
basic chemicals, fine chemicals, IT-related chemicals, agricultural chemicals,
pharmaceuticals, and is aggressively pursuing a large-scale refining and
petrochemical project in Saudi Arabia and the production of materials for liquid
crystal displays (LCDs).
A strongly R & D-oriented company, Sumitomo is the inventor of the Olyset
long-lasting mosquito net technology, capable of remaining effective in
controlling malaria-transmitting mosquitoes for at least 5 years without retreatment.
In its commitment to ensure stable supply in Africa, Sumitomo, in
close cooperation with the WHO, UNICEF, and ExxonMobil, transferred its
Olyset technology to A to Z Textile Mills in Tanzania.
About the United Nations Foundation
The UN Foundation, located in Washington D.C, promotes a more peaceful,
prosperous, and just world through the support of the United Nations. Through
its grant-making and advocacy, and by building innovative public-private
partnerships, the UN Foundation acts to meet the most pressing health,
humanitarian, socio-economic and environmental challenges of the 21st
century. The UN Foundation is a philanthropy founded by Mr. Ted Turner
through his historic billion-dollar commitment to support the UN.
The UN Foundation, along with the American Red Cross, the US Centers for
Disease Control and Prevention (CDC), the United Nations Children’s Fund
(UNICEF), and the World Health Organization (WHO), have led the Measles
Initiative since it was launched in February 2001. The largest integrated health
intervention of its kind, the Measles Initiative has vaccinated 200 million
children and prevented 1.2 million measles deaths and in 2004, began to
evaluate a nationwide approach to combat malaria, distributing more than
800,000 insecticide-treated nets in Togo.
About Exxon Mobil Corporation
Malaria is a disease which threatens both ExxonMobil's African workforce and
its community. ExxonMobil has implemented a comprehensive workplace
malaria control program and since 2000 has given more than $10 million to
fund health organizations and programs to fight malaria in the broader African
community. Grants include support for programs to tackle malaria at the
individual community level, programs to promote the research and
development of new drugs, and projects to advocate for awareness and
support internationally.
|